A Selection of Recent Publications



J Clin Invest 1999 Aug;104(4):515-23

Aberrant prostaglandin synthase 2 expression defines an
antigen-presenting cell defect for insulin-dependent diabetes
mellitus.

Litherland SA, Xie XT, Hutson AD, Wasserfall C, Whittaker DS, She JX, Hofig A, Dennis MA,
Fuller K, Cook R, Schatz D, Moldawer LL, Clare-Salzler MJ



Ann Surg 1999 Jun;229(6):851-8; discussion 858-9

Caspase-3-dependent organ apoptosis early after burn injury.

Fukuzuka K, Rosenberg JJ, Gaines GC, Edwards CK 3rd, Clare-Salzler M, MacKay SL, Moldawer
LL, Copeland EM 3rd, Mozingo DW



J Immunol 1998 Apr 15;160(8):4082-9

Disparate roles for TNF-alpha and Fas ligand in concanavalin
A-induced hepatitis.

Ksontini R, Colagiovanni DB, Josephs MD, Edwards CK 3rd, Tannahill CL, Solorzano CC,
Norman J, Denham W, Clare-Salzler M, MacKay SL, Moldawer LL



J Clin Invest 1992 Sep;90(3):741-8

Prevention of diabetes in nonobese diabetic mice by dendritic cell
transfer.

Clare-Salzler MJ, Brooks J, Chai A, Van Herle K, Anderson C



Immunology 1992 Jul;76(3):478-84

Marked dendritic cell-T cell cluster formation in the pancreatic
lymph node of the non-obese diabetic mouse.

Clare-Salzler M, Mullen Y



Nature 1993 Nov 4;366(6450):69-72

Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase
in murine insulin-dependent diabetes.

Kaufman DL, Clare-Salzler M, Tian J, Forsthuber T, Ting GS, Robinson P, Atkinson MA, Sercarz
EE, Tobin AJ, Lehmann PV



 

return to the MCS lab home page.......